BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 1689237)

  • 1. Beneficial effects of the synthetic trypsin inhibitor camostate in cerulein-induced acute pancreatitis in rats.
    Otsuki M; Tani S; Okabayashi Y; Fuji M; Nakamura T; Fujisawa T; Itoh H
    Dig Dis Sci; 1990 Feb; 35(2):242-50. PubMed ID: 1689237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic oral administration of synthetic trypsin inhibitor camostate reduces amylase release from isolated rat pancreatic acini.
    Otsuki M; Fujii M; Nakamura T; Tani S; Okabayashi Y
    Int J Pancreatol; 1995 Oct; 18(2):135-43. PubMed ID: 8530829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The protective effect of the trypsin inhibitor urinastatin on cerulein-induced acute pancreatitis in rats.
    Tani S; Otsuki M; Itoh H; Nakamura T; Fujii M; Okabayashi Y; Fujisawa T; Baba S
    Pancreas; 1988; 3(4):471-6. PubMed ID: 2459695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of camostate administration for two weeks on experimental pancreatitis in mice and rats.
    Leonhardt U; Seidensticker F; Stöckmann F; Creutzfeldt W
    Pancreas; 1993 Jan; 8(1):98-102. PubMed ID: 7678329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fasting prevents acute pancreatitis induced by cerulein in rats.
    Otsuki M; Tani S; Okabayashi Y; Fujii M; Nakamura T; Fujisawa T; Koide M; Itoh H
    Dig Dis Sci; 1990 Jul; 35(7):840-8. PubMed ID: 2364838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a low-molecular weight serine proteinase inhibitor (camostate) on amylase release from isolated pancreatic acini.
    Göke B; Leferink J; Göke R; Adler G
    Res Exp Med (Berl); 1989; 189(1):33-8. PubMed ID: 2469115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a specific serine protease inhibitor on the rat pancreas: systemic administration of camostate and exocrine pancreatic secretion.
    Göke B; Stöckmann F; Müller R; Lankisch PG; Creutzfeldt W
    Digestion; 1984; 30(3):171-8. PubMed ID: 6209186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice.
    Niederau C; Liddle RA; Williams JA; Grendell JH
    Gut; 1987; 28 Suppl(Suppl):63-9. PubMed ID: 2446964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerulein-induced acute pancreatitis in the rat. Study of pancreatic secretion and plasma VIP and secretin levels.
    Manso MA; San Román JI; de Dios I; García LJ; López MA
    Dig Dis Sci; 1992 Mar; 37(3):364-8. PubMed ID: 1370934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of preventive oral administration of camostate on cerulein-induced pancreatitis in rats.
    Kisfalvi K; Papp M; Friess H; Büchler M; Gorácz UG
    Dig Dis Sci; 1995 Mar; 40(3):546-7. PubMed ID: 7741926
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the effect of lorglumide on pancreatic growth stimulated by camostate in rat and hamster.
    Douglas BR; Woutersen RA; Jansen JB; Rovati LC; Lamers CB
    Life Sci; 1990; 46(4):281-6. PubMed ID: 2304371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas.
    Douglas BR; Woutersen RA; Jansen JB; de Jong AJ; Rovati LC; Lamers CB
    Cancer Res; 1989 May; 49(9):2438-41. PubMed ID: 2706631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of T-0632, a cholecystokininA receptor antagonist, on experimental acute pancreatitis.
    Taniguchi H; Yomota E; Kume E; Shikano T; Endo T; Nagasaki M
    Jpn J Pharmacol; 1997 Feb; 73(2):105-12. PubMed ID: 9074944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic fluid hypersecretion in rats after acute pancreatitis.
    Czakó L; Yamamoto M; Otsuki M
    Dig Dis Sci; 1997 Feb; 42(2):265-72. PubMed ID: 9052504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of trypsin inhibitor (camostate) on pancreas and CCK release in young and old female rats.
    Miyasaka K; Nakamura R; Kitani K
    J Gerontol; 1989 Jul; 44(4):M136-40. PubMed ID: 2738309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the synthetic trypsin inhibitor camostate on the development of N-nitrosobis(2-oxopropyl)amine-induced pancreatic lesions in hamsters.
    Meijers M; van Garderen-Hoetmer A; Lamers CB; Rovati LC; Jansen JB; Woutersen RA
    Cancer Lett; 1991 Dec; 60(3):205-11. PubMed ID: 1756510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptation of the human pancreas to inhibition of luminal proteolytic activity.
    Friess H; Kleeff J; Isenmann R; Malfertheiner P; Büchler MW
    Gastroenterology; 1998 Aug; 115(2):388-96. PubMed ID: 9679044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soybean trypsin inhibitor and cerulein accelerate recovery of cerulein-induced pancreatitis in rats.
    Jurkowska G; Grondin G; Massé S; Morisset J
    Gastroenterology; 1992 Feb; 102(2):550-62. PubMed ID: 1370663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protective effects of long-acting recombinant human pancreatic secretory trypsin inhibitor (R44S-PSTI) in a rat model of cerulein-induced pancreatitis.
    Chen YZ; Ikei S; Yamaguchi Y; Sameshima H; Sugita H; Moriyasu M; Ogawa M
    J Int Med Res; 1996; 24(1):59-68. PubMed ID: 8674801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of trypsin inhibitor on the pancreas and small intestine of mice.
    Ge YC; Morgan RG
    Br J Nutr; 1993 Jul; 70(1):333-45. PubMed ID: 8399113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.